These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 18385183

  • 41. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.
    Massey LA, Micallef C, Paviour DC, O'Sullivan SS, Ling H, Williams DR, Kallis C, Holton JL, Revesz T, Burn DJ, Yousry T, Lees AJ, Fox NC, Jäger HR.
    Mov Disord; 2012 Dec; 27(14):1754-62. PubMed ID: 22488922
    [Abstract] [Full Text] [Related]

  • 42. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, Boesch S, Jaschke W, Poewe W, Wenning GK.
    Neurology; 2003 Mar 25; 60(6):922-7. PubMed ID: 12654954
    [Abstract] [Full Text] [Related]

  • 43. Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants.
    Beliveau V, Müller C, Steiger R, Gizewski ER, Poewe W, Seppi K, Scherfler C.
    Parkinsonism Relat Disord; 2022 Aug 25; 101():43-48. PubMed ID: 35792337
    [Abstract] [Full Text] [Related]

  • 44. Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study.
    Wiblin L, Durcan R, Galna B, Lee M, Burn D.
    J Mov Disord; 2019 Sep 25; 12(3):177-183. PubMed ID: 31390854
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
    Miller N, Nath U, Noble E, Burn D.
    Neurodegener Dis Manag; 2017 Jun 25; 7(3):191-203. PubMed ID: 28632098
    [Abstract] [Full Text] [Related]

  • 50. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov 25; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G, Fabbrini A, Suppa A.
    Handb Clin Neurol; 2019 Nov 25; 165():155-177. PubMed ID: 31727210
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, Manners D, Zappia M, Morgante L, Barone P, Barbiroli B, Quattrone A.
    Brain; 2006 Oct 25; 129(Pt 10):2679-87. PubMed ID: 16815875
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.